Skip to main content
Caplight Logo









Apolo Biotech

Apolo Biotech

Private
Santa FeHealthcare & Life Scienceshttps://apolobiotech.com.ar/

Last Round

Grant

Oct 22, 2025

Total Funding Raised

$2.16M

Company Overview

Apolo Biotech is an agricultural biotechnology company that develops RNA-based technologies for crop improvement and pest control.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Non-AI

Keywords

RNA interferenceRNAibio-inputscrop protectionagtechpest controlnon-transgenicsustainable agriculturebiotechnologyRNA technologybiological pesticidesbiopesticidesbioinformaticsagricultural R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apolo Biotech Comparables

Compare Apolo Biotech with similar companies based on industry and business-model similarity.

Apolo Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RNAissance Ag
84%
Trillium Ag
81%
Omerna Biosolutions
80%

Apolo Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 22, 2025
SAFEOct 16, 2025
GrantOct 14, 2025
GrantMay 15, 2025
GrantMay 9, 2023

Key People

Founding team and executive leadership

Mati Badano

Co-Founder & CEO

Founding Team

Ayelen Porto

COO APOLO Biotech

Executive Team

Apolo Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 201% MoM, from 82 to 247.

  • Feb 21, 2025

    Monthly visitors grew 166% MoM, from 74 to 197.

Apolo Biotech Filings

Explore SEC and related filing metadata, where available.

Apolo Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Apolo Biotech's valuation, stock price, and market status.

Is Apolo Biotech a public or private company?

Apolo Biotech is a private company.

What is the current stock price of Apolo Biotech?

Apolo Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Apolo Biotech worth (valuation)?

Valuation information for Apolo Biotech is not publicly available.

Can I buy Apolo Biotech stock?

Apolo Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Apolo Biotech's last funding round?

Apolo Biotech's most recent funding round was Grant on October 22, 2025.

Who are the main investors in Apolo Biotech?

Key investors in Apolo Biotech include EIT Food, Santander X, Breakthrough Energy Discovery, BioSTL, Core Facilities Access Fund.

Will Apolo Biotech IPO soon?

No public IPO plans have been announced for Apolo Biotech.

How can I track Apolo Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apolo Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSanta Fe
Employee Range21
Year Founded2022
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?